Azerbaijan vs Ghana: Treatment success rate for patients treated for MDR-TB
Azerbaijan
67.0%
in 2022
Ghana
67.0%
in 2022
Azerbaijan rank
106th
Ghana rank
106th
Treatment success rate for patients treated for MDR-TB over time
- Azerbaijan
- Ghana
How they compare
Azerbaijan currently reports 67.0% against 67.0% in Ghana, a difference of 0.0%.
The two have swapped places 5 times across 13 shared years of data; in 2010 it was Azerbaijan ahead.
Azerbaijan ranks 106th and Ghana ranks 106th of 163 countries.
Ghana has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Azerbaijan | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 58.8% | 62.3% | 3.5% | Ghana |
| 2020s | 64.3% | 71.7% | 7.3% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Azerbaijan or Ghana?
- Azerbaijan, at 67.0% against 67.0% in Ghana as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Azerbaijan and Ghana?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Ghana?
- 13 years are reported by both, from 2010 to 2022.
- How do Azerbaijan and Ghana rank globally for treatment success rate for patients treated for mdr-tb?
- Azerbaijan ranks 106th and Ghana ranks 106th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.